Journal Information
Share
Download PDF
More article options
Original Article
Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP
Jessica Gonzáleza,b,
Corresponding author
jgonzalezgutierrez88@gmail.com

Corresponding author.
, Luis M. Seijob,c, Juan P. de-Torresd,e, Iván D. Beníteza,b, María del Mar Ocónd, Ferran Barbéa,b, Juan P. Wisniveskyf, Javier J. Zuluetag
a Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain
b CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain
c Pulmonary Department, Clínica Universidad de Navarra, Madrid, Spain
d Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Spain
e Navarra's Health Research Institute (IDISNA), Pamplona, Spain
f Divisions of General Internal Medicine and Pulmonary and Critical Care Medicine, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA
g Pulmonary, Critical Care and Sleep Division, Mount Sinai Morningside Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Article

This article is available in English

Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP

Jessica González, Luis M. Seijo, Juan P. de-Torres, Iván D. Benítez, María del Mar Ocón, Ferran Barbé, Juan P. Wisnivesky, Javier J. Zulueta
10.1016/j.arbres.2024.05.009
Arch Bronconeumol. 2024;60:559-64
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?